CC
VRTX icon

Codex Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Codex Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.91M Hold
11,750
– – 2.39% 18
2023
Q4 		$4.78M Hold
11,750
– – 2.79% 17
2023
Q3 		$4.09M Buy
11,750
+2,000
+21% +$699K 2.64% 17
2023
Q2 		$3.43M Buy
9,750
+2,050
+27% +$691K 2.21% 19
2023
Q1 		$2.43M Hold
7,700
– – 1.67% 22
2022
Q4 		$2.22M Hold
7,700
– – 1.86% 20
2022
Q3 		$2.23M Buy
+7,700
New +$2.22M 1.91% 21

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Codex Capital's VRTX Position: Q1 2024 in Review

Codex Capital held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2024 at 11,750 shares worth $4.91M. The position accounts for 2.39% of the portfolio, ranked #18.

Codex Capital first reported a position in VRTX in Q3 2022 and has held it in 7 quarters since. 1,493 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

  • Codex Capital held 11,750 shares of Vertex Pharmaceuticals worth $4.91M as of Q1 2024.
  • Codex Capital left its Vertex Pharmaceuticals share count unchanged in Q1 2024.
  • Vertex Pharmaceuticals made up 2.39% of Codex Capital's portfolio in Q1 2024, its #18 holding.
  • Codex Capital first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
  • 1,493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Codex Capital's 13F filing for Q1 2024, filed 7 May 2024.